HEC89736
HEC89736-P-01
Phase 1 small_molecule terminated
Quick answer
HEC89736 for Relapsed or Refractory B-cell Hematologic Malignancies is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Relapsed or Refractory B-cell Hematologic Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated